Abbott Laboratories

Registered Principal Details

Business Or Interest:
Discover, manufacture and sell health care products.

Lobbying Interests:
Medicaid as it pertains to prescription drugs. Regulations related to prescription drug industry.

CEO Name:
Miles White
Regional Director

Contact
CS
Charles Seeds
1406 Plumwood Drive
Libertyville, IL 60048
(847) 816-3935
(847) 281-9408
charles.seeds@abbott.com
www.abbott.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 151
Assembly Bill 151
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.

Bill Text and History

Other
Notification Date
6/27/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 101
Senate Bill 101
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.

Bill Text and History

Other
Notification Date
6/27/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 373
Senate Bill 373
Relating to: changes to product liability law and the law governing remedies against manufacturers, distributors, sellers, and promoters of a product.

Bill Text and History

None
Notification Date
1/12/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
September 2011 Special Session Assembly Bill 13
September 2011 Special Session Assembly Bill 13
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.

Bill Text and History

For
Notification Date
10/21/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Budget Bill Subjects

Health Services: Medical Assistance and Related Programs
Biennial budget bill treatment of matter relating to
Health Services: Medical Assistance and Related Programs

Notification Date
5/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Comments
Medicaid reimbursement

Notification Date
5/18/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Comments
drug substitution

Topics Not Yet Assigned A Bill Or Rule Number

Health care reform including health insurance exchanges
Development, drafting or introduction of a proposal relating to
Health care reform including health insurance exchanges

Action Intended To Affect
Legislative matter

Notification Date
7/26/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Health care reform including health insurance exchanges
Development, drafting or introduction of a proposal relating to
Health care reform including health insurance exchanges

Action Intended To Affect
Legislative Matter

Notification Date
7/26/2012
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Combined reporting of corporate income.
Development, drafting or introduction of a proposal relating to
Combined reporting of corporate income.

Action Intended To Affect
Both Legislative Matter and Rule

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Medicaid funding.
Development, drafting or introduction of a proposal relating to
Medicaid funding.

Action Intended To Affect
Both Legislative Matter and Rule

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Relating to prohibiting the manufacture and sale of bottles and cups containing bisphenal-A.
Development, drafting or introduction of a proposal relating to
Relating to prohibiting the manufacture and sale of bottles and cups containing bisphenal-A.

Action Intended To Affect
Legislative Matter

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Restrictions on material provided to physicians by pharmaceutical and healthcare product manufacturers.
Development, drafting or introduction of a proposal relating to
Restrictions on material provided to physicians by pharmaceutical and healthcare product manufacturers.

Action Intended To Affect
Both Legislative Matter and Rule

Notification Date
1/1/2011
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Total Lobbying Effort

  2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
Total Lobbying Expenditures 2011
January - June
$3,300.00
2011
July - December
$7,650.00
2012
January - June
$5,062.50
2012
July - December
$2,800.00
Total $18,812.50
Total Hours Communicating 2011
January - June
2.50
2011
July - December
9.25
2012
January - June
4.50
2012
July - December
0.00
Total 16.25
Total Hours Other 2011
January - June
14.00
2011
July - December
41.75
2012
January - June
29.25
2012
July - December
14.00
Total 99.00

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
10%
2011
July - December
20%
2012
January - June
2012
July - December
Total 10%
Relating to: copayments, deductibles, or coinsurance for oral chemotherapy and injected or intravenous chemotherapy.
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
10%
2011
July - December
20%
2012
January - June
2012
July - December
Total 10%
Relating to: providing immunity from liability to drug and device manufacturers and sellers under certain circumstances.
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
2011
July - December
50%
2012
January - June
2012
July - December
Total 23%

Budget Bill Subjects

2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
70%
2011
July - December
2012
January - June
2012
July - December
Total 10%

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
2011
July - December
2012
January - June
90%
2012
July - December
Total 26%
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
2011
July - December
2012
January - June
2012
July - December
100%
Total 12%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
10%
2011
July - December
10%
2012
January - June
2012
July - December
Total 6%

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2011
January - June
2011
July - December
2012
January - June
2012
July - December
Total
2011
January - June
2011
July - December
2012
January - June
10%
2012
July - December
Total 3%

Filed Statements of Lobbying Activity and Expenditures